Northern Trust Corp Portage Biotech Inc. Transaction History

Northern Trust Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.16 - $11.95 $170,522 - $394,911	-33,047 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$6.57 - $12.0 $4,447 - $8,124	-677 Reduced 2.01%	33,047 $217,000
Q4 2021 Feb 08, 2022	SELL	$10.73 - $23.74 $26,503 - $58,637	-2,470 Reduced 6.82%	33,724 $362,000
Q3 2021 Nov 15, 2021	SELL	$13.65 - $22.4 $115,206 - $189,056	-8,440 Reduced 18.91%	36,194 $735,000
Q2 2021 Aug 13, 2021	BUY	$20.96 - $42.81 $935,528 - $1.91 Million	44,634 New	44,634 $935,000

28.4K

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $68.5M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.